0000000000019749

AUTHOR

Matilde Merino-sanjuán

0000-0003-4956-0247

showing 53 related works from this author

Development of an ion-pair to improve the colon permeability of a low permeability drug: Atenolol.

2016

Abstract To ensure the optimal performance of oral controlled release formulations, drug colon permeability is one of the critical parameters. Consequently developing this kind of formulations for low permeability molecules requires strategies to increase their ability to cross the colonic membrane. The objective of this work is to show if an ion-pair formation can improve the colon permeability of atenolol as a low permeability drug model. Two counter ions have been tested: brilliant blue and bromophenol blue. The Distribution coefficients at pH 7.00 (DpH7) of atenolol, atenolol + brilliant blue and atenolol + bromophenol blue were experimentally determined in n-octanol. Moreover, the colo…

DrugMaleColonmedia_common.quotation_subjectPharmaceutical ScienceBromophenol blue02 engineering and technology030226 pharmacology & pharmacyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicineLow permeabilityAnimalsRats WistarColoring Agentsmedia_commonchemistry.chemical_classificationChromatographyBenzenesulfonates021001 nanoscience & nanotechnologyAtenololPermeability (earth sciences)MembranechemistryAtenololParacellular transportDelayed-Action PreparationsBromphenol BlueCounterion0210 nano-technologymedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Erratum: Mangas-Sanjuán, V.; et al. Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the De…

2020

Demonstration of similar microstructure is essential for demonstrating the equivalence of generic topical products since the microstructure of semisolids may affect the drug release. The objective of this study was to compare the microstructure-defining physical parameters of different batches of a reference ointment containing calcipotriol and betamethasone (Daivobet 50 µg/0.5 mg/g) in order to define the acceptance range that allows concluding equivalence between these batches. Being batches of the same reference product, they are expected to be clinically equivalent and possess similar microstructure. The 90% confidence intervals for the test/reference ratio of these physical parameters …

lcsh:Pharmacy and materia medican/aPublished ErratumPharmaceutical ScienceThermodynamicsPharmaceuticslcsh:RS1-441ErratumMicrostructureEquivalence (measure theory)MathematicsPharmaceutics
researchProduct

In vitro–in vivocorrelations: general concepts, methodologies and regulatory applications

2015

The major objective of in vitro-in vivo correlations is to be able to use in vitro data to predict in vivo performance serving as a surrogate for an in vivo bioavailability test and to support biowaivers. Therefore, the aims of this review are: (i) to clarify the factors involved during bio-predictive dissolution method development; and (ii) the elements that may affect the mathematical analysis in order to exploit all information available. This article covers the basic aspects of dissolution media and apparatus used in the development of in vivo predictive dissolution methods, including the latest proposals in this field as well as the summary of the mathematical methods for establishing …

PharmacologyChemistryChemistry PharmaceuticalOrganic ChemistryBiological AvailabilityPharmaceutical SciencePharmacologyIn vitroBioavailabilityIVIVCSolubilityIn vivoDrug DiscoveryAnimalsHumansIn vitro in vivoDrug Development and Industrial Pharmacy
researchProduct

Development of antibiotic loaded biodegradable matrices to prevent superficial infections associated to total knee arthroplasty.

2019

Abstract Development of a pharmaceutical form for the superficial infections related with arthroplasties would be helpful for clinical practice. In this context, we set out to evaluate ciprofloxacin and gentamicin elution from systems based on chitosan. Films and semisolid hydrogels containing chitosan alone (2%) or in combination with gelatin (6%) or different proportions (from 12% to 36%) of tetrakis-(hydroxymethyl)-phosphonium-chloride (THPC) were tested as delivery systems. Different antibiotic doses were assayed (0.5 mg/cm2,1 mg/cm2 and 2 mg/cm2). Antibiotic release was studied for each formulation. In vitro cytocompatibility studies and a simulation exercise for bioactivity evaluation…

food.ingredientmedicine.drug_classCell SurvivalSurface PropertiesAntibioticsContext (language use)macromolecular substances02 engineering and technologyPharmacology01 natural sciencesGelatinChitosanchemistry.chemical_compoundMiceColloid and Surface ChemistryfoodOrganophosphorus CompoundsCiprofloxacin0103 physical sciencesmedicineAnimalsPhysical and Theoretical ChemistryParticle SizeCytotoxicityArthroplasty Replacement KneeCell ProliferationChitosan010304 chemical physicstechnology industry and agricultureSurfaces and InterfacesGeneral MedicineFibroblasts021001 nanoscience & nanotechnologyAnti-Bacterial Agentscarbohydrates (lipids)CiprofloxacinchemistrySelf-healing hydrogelsNIH 3T3 CellsGentamicinGentamicins0210 nano-technologyBiotechnologymedicine.drugColloids and surfaces. B, Biointerfaces
researchProduct

Impact of nutritional status on the oral bioavailability of leucine administered to rats as part of a standard enteral diet.

2010

Summary Background To investigate the absorption and relative bioavailability of leucine administered orally as part of an enteral diet in well and malnourished animals. Methods Two groups – RN (regular nutrition) and PCR (protein-calorie restricted) – were fed with different diets for 23–25 days. Rats from each group were assigned randomly to one of three treatments (water, T-Diet Plus Standard ® (problem) or Isosource ST ® (reference)) administered in single ( N  = 76) or multiple ( N  = 39) doses. Blood samples were assayed for leucine content. Area under the curve (AUC) was calculated by non-compartmental analysis. Log-transformed AUC(s) were statistically compared by analysis of varian…

MaleAdministration OralBiological AvailabilityNutritional StatusCritical Care and Intensive Care MedicineMultiple dosingEnteral administrationAbsorptionAnimal scienceEnteral NutritionLeucineDiet Protein-RestrictedMedicineAnimalsFood scienceRats WistarNutrition and DieteticsDose-Response Relationship Drugbusiness.industryArea under the curveNutritional statusConfidence intervalBioavailabilityDietRatsArea Under CurveAnalysis of varianceLeucinebusinessEnergy IntakeClinical nutrition (Edinburgh, Scotland)
researchProduct

Relationship Between Glucocerebrosidase Activity and Clinical Response to Enzyme Replacement Therapy in Patients With Gaucher Disease Type I

2018

The quantification of enzyme activity in the patient treated with enzyme replacement therapy (ERT) has been suggested as a tool for dosage individualization, so we conducted a study to evaluate the relationship between glucocerebrosidase activity and clinical response in patients with Gaucher disease type I (GD1) to ERT. The study included patients diagnosed with GD1, who were being treated with ERT, and healthy individuals. Markers based on glucocerebrosidase activity measurement in patients' leucocytes were studied: enzyme activity at 15 min. post-infusion (Act75 ) reflects the amount of enzyme that is distributed in the body post-ERT infusion, and accumulated glucocerebrosidase activity …

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyDiseaseToxicologySeverity of Illness IndexGastroenterology03 medical and health sciencesGlucocerebrosidase activity0302 clinical medicineStatistical significanceInternal medicineLeukocytesHumansMedicineEnzyme Replacement TherapyIn patientProspective Studies030212 general & internal medicineInverse correlationAgedEnzyme AssaysPharmacologyGaucher DiseaseDose-Response Relationship Drugbiologybusiness.industryArea under the curvenutritional and metabolic diseasesGeneral MedicineEnzyme replacement therapyMiddle AgedEnzyme assayTreatment Outcome030220 oncology & carcinogenesisbiology.proteinGlucosylceramidaseFemalebusinessBiomarkersFollow-Up StudiesBasic & Clinical Pharmacology & Toxicology
researchProduct

Relevance of Multidrug Resistance Proteins on the Clinical Efficacy of Cancer Therapy

2005

Variations in drug uptake and efflux, as well as changes in intracellular drug entrapment and distribution may represent important resistance mechanisms to cancer therapy. A variety of ATP binding cassette transporters (ABC) localised in multiple cell membranes is implied in those phenomena, representing a mechanism of protection of cells against xenobiotics. Many cancer cell lines over express some ABC transporters, especially p-glycoprotein, MRP1 and BCRP. This over expression is related to worse cancer treatment outcome and, in some cases, reduced overall survival of cancer patients. This paper reviews the location and physiological role of the three transporters mentioned and also descr…

Drugmedia_common.quotation_subjectCellCancer therapyPharmaceutical ScienceAntineoplastic AgentsATP-binding cassette transporterTransporterPharmacologyBiologyTreatment Outcomemedicine.anatomical_structureDrug Resistance NeoplasmNeoplasmsmedicineAnimalsHumansEffluxMultidrug Resistance-Associated ProteinsIntracellularMultidrug Resistance-Associated Proteinsmedia_commonCurrent Drug Delivery
researchProduct

In vitro skin penetration of bronidox, bronopol and formaldehyde from cosmetics

2020

The objective was to evaluate the influence of the formulation in the in vitro transdermal absorption through pig ear skin of three preservatives, bronopol, bronidox and formaldehyde as well as the absorption of formaldehyde from bronopol and dimethyloldimethyl hydantoin (DMDM hydantoin). An aqueous solution, an O/W emulsion and a hydrogel were assayed. Bronidox and bronopol absorption depends on the formulation. The O/W emulsion was the system that least promoted absorption of bronidox while the absorption of bronopol was lower from the hydrogel. The aqueous solution provided maximal transdermal absorption of both preservatives. Moreover, the transdermal absorption of formaldehyde released…

SwineSkin AbsorptionFormaldehydeHydantoinCosmeticsAbsorption (skin)010501 environmental sciencesToxicology030226 pharmacology & pharmacy01 natural sciencesDMDM hydantoinDioxanes03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug StabilityFormaldehydeAnimals0105 earth and related environmental sciencesBronidoxAqueous solutionChromatographyPreservatives PharmaceuticalHydrogelsGeneral MedicineBronopolchemistryPropylene GlycolsEmulsionEmulsionsRegulatory Toxicology and Pharmacology
researchProduct

Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

2020

MBQ-167 is a dual inhibitor of the Rho GTPases Rac and Cdc42 that has shown promising results as an anti-cancer therapeutic at the preclinical stage. This drug has been tested in vitro and in vivo in metastatic breast cancer mouse models. The aim of this study is to develop a physiologically based pharmacokinetic/pharmacodynamic (PBPK-PD) model of MBQ-167 to predict tumor growth inhibition following intraperitoneal (IP) administration in mice bearing Triple Negative and HER2+ mammary tumors. PBPK and Simeoni tumor growth inhibition (TGI) models were developed using the Simcyp V19 Animal Simulator. Our developed PBPK framework adequately describes the time course of MBQ-167 in each of the mo…

Physiologically based pharmacokinetic modellinglcsh:RS1-441Pharmaceutical ScienceSpleenPharmacologyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinebreast cancerPharmacokineticsIn vivomedicinePotency030304 developmental biology0303 health sciencesMammary tumorbusiness.industryMBQ-167medicine.diseaseMetastatic breast cancermedicine.anatomical_structure030220 oncology & carcinogenesisPharmacodynamicsRac inhibitorphysiologically based pharmacokinetic modelingbusinessPharmaceutics
researchProduct

In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model.

2015

Our aim is to develop and to validate the in situ closed loop perfusion method in rat colon and to compare with small intestine and Caco-2 cell models. Correlations with human oral fraction absorbed (Fa) and human colon fraction absorbed (Fa_colon) were developed to check the applicability of the rat colon model for controlled release (CR) drug screening. Sixteen model drugs were selected and their permeabilities assessed in rat small intestine and colon, and in Caco-2 monolayers. Correlations between colon/intestine/Caco-2 permeabilities versus human Fa and human Fa_colon have been explored to check model predictability and to apply a BCS approach in order to propose a cut off value for CR…

In situAbsorption (pharmacology)MalePathologymedicine.medical_specialtyColonCellPharmaceutical SciencePermeabilityCell Line TumorIntestine SmallmedicineAnimalsHumansRats Wistarbusiness.industryBiological TransportControlled releaseMolecular biologydigestive system diseasesSmall intestineRatsPerfusionmedicine.anatomical_structureIntestinal AbsorptionCaco-2Paracellular transportDelayed-Action PreparationsModels AnimalCaco-2 CellsbusinessPerfusionJournal of pharmaceutical sciences
researchProduct

Current Evidence, Challenges, and Opportunities of Physiologically Based Pharmacokinetic Models of Atorvastatin for Decision Making

2021

Atorvastatin (ATS) is the gold-standard treatment worldwide for the management of hypercholesterolemia and prevention of cardiovascular diseases associated with dyslipidemia. Physiologically based pharmacokinetic (PBPK) models have been positioned as a valuable tool for the characterization of complex pharmacokinetic (PK) processes and its extrapolation in special sub-groups of the population, leading to regulatory recognition. Several PBPK models of ATS have been published in the recent years, addressing different aspects of the PK properties of ATS. Therefore, the aims of this review are (i) to summarize the physicochemical and pharmacokinetic characteristics involved in the time-course o…

Physiologically based pharmacokinetic modellingModel predictionAtorvastatinPopulationPharmaceutical ScienceReviewTarget populationComputational biologyP-glycoprotein030226 pharmacology & pharmacy03 medical and health sciencesPharmacy and materia medica0302 clinical medicinePharmacokineticsmedicineopen acid formeducationeducation.field_of_studybusiness.industrysolubilityatorvastatinactive metabolitesRS1-441lactonizationDose optimizationMetabolic enzymes030220 oncology & carcinogenesisbusinessmedicine.drugPharmaceutics
researchProduct

Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.

2008

Abstract Different known percutaneous chemical enhancers and iontophoresis have been tested in-vitro to study their ability to increase transdermal absorption of nortriptyline hydrochloride (20 mg mL−1). The chemicals 1-dodecanol, Span 20, Azone, (R)-(+)-limonene or isopropyl myristate were used as an overnight pretreatment at 5% (w/w) in ethanol. Furthermore, isopropyl myristate (20%, w/w) and propylene glycol (15%, w/w) were tested in the same vehicle. Iontophoresis was applied directly to the nortriptyline hydrochloride donor solution for three different concentrations (20, 2 and 0.5 mgmL−1). The chemical enhancers slightly increased the nortriptyline transdermal flux but iontophoresis w…

AdultSkin AbsorptionPharmaceutical ScienceNortriptylinePharmacologyAntidepressive Agents TricyclicIn Vitro TechniquesAdministration CutaneousPermeabilityDiffusionchemistry.chemical_compoundCyclohexenesmedicineHumansIsopropyl myristateTransdermalHexosesPharmacologyChromatographyEthanolIontophoresisMyristatesTerpenesPenetration (firestop)AzepinesIontophoresisMiddle AgedchemistryNortriptyline HydrochlorideDodecanolFemaleNortriptylineEpidermisPharmaceutical VehiclesHEPESAzoneLimonenemedicine.drugThe Journal of pharmacy and pharmacology
researchProduct

Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monocultu…

2017

The Caco-2 cellular monolayer is a widely accepted in vitro model to predict human permeability but suffering from several and critical limitations. Therefore, some alternative cell cultures to mimic the human intestinal epithelium, as closely as possible, have been developed to achieve more physiological conditions, as the Caco-2/HT29-MTX coculture and the triple Caco-2/HT29-MTX/Raji B models. In this work the permeability of 12 model drugs of different Biopharmaceutical Classification System (BCS) characteristics, in the coculture and triple coculture models was assessed. Additionally, the utility of both models to classify compounds according to the BCS criteria was scrutinized. The obta…

0301 basic medicineDrugColonmedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyBiologydigestive systemPermeability03 medical and health sciencesCell Line TumorDrug DiscoverymedicineLow permeabilityHumansIntestinal Mucosamedia_commonHt29 mtxIntestinal permeability021001 nanoscience & nanotechnologymedicine.diseaseIntestinal epitheliumCoculture Techniques030104 developmental biologyIntestinal AbsorptionCaco-2Cell culturePermeability (electromagnetism)ImmunologyCancer researchMolecular MedicineCaco-2 Cells0210 nano-technologyHT29 CellsMolecular Pharmaceutics
researchProduct

Adsorption of methotrexate and calcium leucovorin onto cholestyramine in vitro.

2003

Abstract Methotrexate (MTX), an antimetabolite of folic acid, is a drug widely used in the treatment of different types of cancer. When high doses are administered, it is necessary to interrupt its action by administering calcium leucovorin (CaL). The main pathway of MTX and CaL elimination in humans occurs through the kidney, but about 10% is excreted in the faeces via the bile. Drugs, foods and sorbents in intestinal lumen modify MTX and CaL reabsorption. Individual and simultaneous studies on the adsorption of MTX and CaL from aqueous phosphate buffer by cholestyramine were carried out in order to calculate the adsorption process of MTX and CaL to cholestyramine, and to characterize the …

musculoskeletal diseasesDrugAntimetabolites Antineoplasticmedicine.drug_classmedia_common.quotation_subjectCholestyramine ResinLeucovorinPharmaceutical SciencePharmacologyAntimetabolitechemistry.chemical_compoundmedicineIon-exchange resinAnion Exchange Resinsmedia_commonLeucovorin CalciumKidneyCholestyramineChromatographyChemistryHydrogen-Ion Concentrationstomatognathic diseasesmedicine.anatomical_structureMethotrexateAntifolateMethotrexateAdsorptionmedicine.drugInternational journal of pharmaceutics
researchProduct

Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis i…

2017

The main objective of this study was to develop a pharmacokinetic model in order to describe the intestinal absorption of erlotinib in rat and to quantify the interaction of levofloxacin on this process in well- and under-nourished rats. Absorption studies were performed in male Wistar rats. Concentration-time profiles in proximal and distal intestine were analysed through non-linear mixed effect modelling using the NONMEM software version 7.3. Simulations were performed in order to explore the influence of covariates on the apparent absorption rate constant. A passive absorption and an active secretion process best-described erlotinib absorption from lumen to enterocyte. The developed mode…

PopulationPharmaceutical SciencePharmacology030226 pharmacology & pharmacyIntestinal absorption03 medical and health sciences0302 clinical medicineIntestinal mucosaPharmacokineticsmedicineheterocyclic compoundsPharmacology (medical)educationErlotinib HydrochlorideneoplasmsPharmacologyeducation.field_of_studybusiness.industryGeneral MedicineDrug interactionrespiratory tract diseasesNONMEM030220 oncology & carcinogenesisErlotinibbusinessmedicine.drugBiopharmaceutics & Drug Disposition
researchProduct

Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium

2012

Abstract Objectives The aim of this study was to prepare diclofenac/hydroxypropylmethylcellulose (HPMC) and diclofenac-loaded nanoparticles/HPMC films as potential systems for ocular delivery. Methods Two different concentration of the polymer were used: 1.5 and 2.0% w/v. Chitosan–hyaluronic acid nanoparticles were prepared by the ionotropic gelation technique. Nanoparticles were characterized by transmission electron microscopy, dynamic light scattering, drug encapsulation efficiency and rheological studies. In-vitro drug studies and corneal penetration release studies were carried out. Drug release mechanism was finally evaluated by fitting the Ritger and Peppas equation to data. In addit…

DiclofenacPolymersPharmaceutical ScienceNanoparticleAdministration OphthalmicMethylcellulosePharmacologyPermeabilityDosage formDrug Delivery SystemsHypromellose DerivativesDiclofenacDynamic light scatteringmedicineHyaluronic AcidDosage FormsPharmacologychemistry.chemical_classificationChitosanChemistryAnti-Inflammatory Agents Non-SteroidalDiclofenac SodiumPolymerPermeationHypromellose DerivativesNanoparticlesmedicine.drugNuclear chemistryJournal of Pharmacy and Pharmacology
researchProduct

Estimators and confidence intervals of f2 using bootstrap methodology for the comparison of dissolution profiles

2021

Abstract Background and objectives: The most widely used method to compare dissolution profiles is the similarity factor f 2 . When this method is not applicable, the confidence interval of f 2 using bootstrap methodology has been recommended instead. As neither details of the estimator nor the types of confidence intervals are described in the guidelines, the suitability of five estimators and fourteen types of confidence intervals were investigated in this study by simulation. Methods: One million individual dissolution profiles were simulated for the reference and test populations with predefined target population f 2 values, where random samples of different sizes were drawn without rep…

PercentileSimilarity (network science)Sample size determinationStatisticsStatistical inferenceEstimatorHealth InformaticsPoint estimationExpected valueSoftwareConfidence intervalComputer Science ApplicationsMathematicsComputer Methods and Programs in Biomedicine
researchProduct

Quality Improvement Project to Evaluate Discharge Prescriptions in Children With Cystic Fibrosis

2019

Introduction: Cystic Fibrosis (CF) requires multiple pharmaceutical treatments, elevating the risk of medication errors (ME), which may compromise patient safety. This study aimed to improve the quality of discharge prescriptions (DPs) using indicators following admissions for IV antibiotics in pediatric CF patients. Methods: This project involved a longitudinal observational retrospective descriptive study followed by a longitudinal quasi-experimental prospective phase between January 2013 and December 2016 in CF patients admitted to a London Children's Hospital. The CF pharmacist reviewed DPs. Six rights of medication administration were defined (6R): dose, drug, frequency, duration of tr…

medicine.medical_specialtyQuality managementbusiness.industryFarmacèutic i pacientPharmacistMEDLINERetrospective cohort studymedicine.diseaseCystic fibrosisPatient safetyIndividual QI projects from single institutionsEmergency medicinemedicineObservational studyMedical prescriptionbusinessTecnologia farmacèutica
researchProduct

In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluis…

2015

Intestinal drug permeability has been recognized as a critical determinant of the fraction dose absorbed, with direct influence on bioavailability, bioequivalence and biowaiver. The purpose of this research was to compare intestinal permeability values obtained by two different intestinal rat perfusion methods: the single-pass intestinal perfusion (SPIP) model and the Doluisio (closed-loop) rat perfusion method. A list of 15 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed) was constructed. We assessed the rat intestinal permeability of these 15 model drugs in both SPIP and the Doluisio methods, and evaluated the co…

In situMaleSingle passIntestinal permeabilitybusiness.industryPharmaceutical ScienceBioequivalencePharmacologymedicine.diseaseBiopharmaceutics Classification SystemModels BiologicalPermeabilityBioavailabilityRatsPerfusionPermeability (earth sciences)Intestinal AbsorptionPharmaceutical PreparationsmedicineAnimalsHumansIntestinal MucosaRats WistarbusinessPerfusionInternational journal of pharmaceutics
researchProduct

A Bayesian Method for Predicting 5‐Fluorouracil Pharmacokinetic Parameters Following Short‐Term Infusion in Patients With Colorectal Cancer

2003

Abstract The objective of this study was to develop a population pharmacokinetic model and validate it using a Bayesian approach for predicting, a priori and a posteriori , the individual volume of distribution ( V d ) and clearance ( Cl ) of 5‐fluorouracil (5‐FU) given as short‐term intravenous infusion in weekly and multiple doses. Forty‐four patients were divided in group A (5‐FU weekly doses) including 27 patients with nonmetastatic colorectal adenocarcinoma treated with 450 mg/m 2 of 5‐FU, 1 day per week for 48 doses, plus oral levamisol (50 mg/8 h) for 3 days, every 15 days and group B (5‐FU multiple doses) including 17 patients with metastatic colorectal adenocarcinoma, receiving 5‐F…

AdultMaleAntimetabolites Antineoplasticmedicine.medical_specialtyPopulationUrologyPharmaceutical ScienceRenal functionModels BiologicalDrug Administration ScheduleFolinic acidPharmacokineticsInternal medicineBlood plasmamedicineHumansInfusions IntravenouseducationAgedBody surface areaVolume of distributioneducation.field_of_studybusiness.industryBayes TheoremMiddle AgedNONMEMEndocrinologyArea Under CurveFemaleFluorouracilColorectal Neoplasmsbusinessmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Physico-Chemical Stability of Admixtures of Vinflunine Used in Clinical Practice.

2021

Procedure of administration of vinflunine is complex and consists of an Y-site injection with fluid at different speeds. Dose is diluted with 100 mL of 0.9% sodium chloride or 5% glucose and infused with half of the 500 mL bag of the fluid over 20 min; after that, the remaining fluid is administered at 300 mL/h. In this study, chemical stability and physical compatibility of vinflunine diluted with in 500 mL of both fluids were evaluated to simplify the administration procedure (infusion of mixture on 20 min followed by 250 mL of fluid at 300 mL/h). Physical compatibility and chemical stability were evaluated at two temperatures and protected from and exposed to light. Physical compatibilit…

SodiumPharmaceutical ScienceExpiration datechemistry.chemical_element02 engineering and technologySodium ChlorideVinblastine030226 pharmacology & pharmacy03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug StabilityChromatography High Pressure LiquidChromatographyVinflunineChemistryTemperatureVinflunine021001 nanoscience & nanotechnologyDilutionClinical PracticeAdministrationGravimetric analysisChemical stability0210 nano-technologyChemical stabilityPhysical compatibilityJournal of pharmaceutical sciences
researchProduct

Multi-output Model with Box-Jenkins Operators of Quadratic Indices for Prediction of Malaria and Cancer Inhibitors Targeting Ubiquitin- Proteasome Pa…

2016

The ubiquitin-proteasome pathway (UPP) is the primary degradation system of short-lived regulatory proteins. Cellular processes such as the cell cycle, signal transduction, gene expression, DNA repair and apoptosis are regulated by this UPP and dysfunctions in this system have important implications in the development of cancer, neurodegenerative, cardiac and other human pathologies. UPP seems also to be very important in the function of eukaryote cells of the human parasites like Plasmodium falciparum, the causal agent of the neglected disease Malaria. Hence, the UPP could be considered as an attractive target for the development of compounds with Anti-Malarial or Anti-cancer properties. R…

Proteasome Endopeptidase ComplexDNA repairDatabases PharmaceuticalAntineoplastic AgentsComputational biologyBioinformatics01 natural sciencesBiochemistryAntimalarialsUbiquitinNeoplasmsDrug DiscoveryHumansMolecular Targeted TherapyMolecular BiologybiologyDrug discoveryUbiquitinComputational BiologyCell BiologyGeneral MedicineCell cyclechEMBL0104 chemical sciencesMalaria010404 medicinal & biomolecular chemistryProteasomeProteolysisbiology.proteinSignal transductionFunction (biology)Current proteinpeptide science
researchProduct

PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.

2018

The oral controlled release (CR) formulations have become more important in recent years. Among them, the polymeric nanoparticles have been thoroughly studied during the last decades, consequently they are extensively employed for a broad range of applications and drugs. The objective of this research was to develop polymeric nanoparticles (NPs) of ibuprofen with poly(lactic-co-glycolic) acid (PLGA) as polymer, and to test their applicability for oral CR formulations development. Different proportions of drug/polymer were employed to develop the ibuprofen NPs and their in vitro release profiles were analysed. The in situ segmental permeability of ibuprofen was tested in Wistar rat and demon…

DrugMaleColonPolymersmedia_common.quotation_subjectPharmaceutical ScienceIbuprofen02 engineering and technologyAbsorption (skin)030226 pharmacology & pharmacyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivomedicineAnimalsLactic AcidRats Wistarmedia_commonchemistry.chemical_classificationDrug CarriersChromatographyorganic chemicalstechnology industry and agriculturePolymer021001 nanoscience & nanotechnologyIbuprofenControlled releaseRatsPLGAchemistryIntestinal AbsorptionPermeability (electromagnetism)Delayed-Action PreparationsNanoparticles0210 nano-technologyPolyglycolic Acidmedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Use of nonlinear mixed effect modeling for the intestinal absorption data: application to ritonavir in the rat.

2005

The aim of this study is to investigate in situ the mechanisms involved in the gastrointestinal absorption of ritonavir in the rat, as an animal model for preclinical studies of anti-HIV agents in vivo. Four ritonavir solutions (40, 27, 13 and 7 microM) in the presence of 1% dimethylsulfoxide (DMSO) were perfused in the small intestine of anaesthetised rats. Effects of DMSO on the intestinal permeability were investigated using solutions containing antipyrine 1.33 mM and ritonavir 7 microM with and without 1% of DMSO. Antipyrine and ritonavir transport was not modified in the presence of 1% of DMSO. The population pharmacokinetic parameters of the ritonavir intestinal transport were obtaine…

MalePopulationPharmaceutical ScienceAbsorption (skin)PharmacologyIntestinal absorptionPharmacokineticsimmune system diseasesIn vivoIntestine SmallmedicineAnimalsHumansDimethyl SulfoxideRats Wistareducationeducation.field_of_studyIntestinal permeabilityRitonavirChemistryvirus diseasesGeneral MedicineHIV Protease Inhibitorsmedicine.diseaseSmall intestineRatsPerfusionmedicine.anatomical_structureIntestinal AbsorptionNonlinear DynamicsSolubilityModels AnimalRitonavirBiotechnologymedicine.drugEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Assessment of the Inter-Batch Variability of Microstructure Parameters in Topical Semisolids and Impact on the Demonstration of Equivalence

2019

Demonstration of similar microstructure is essential for demonstrating the equivalence of generic topical products since the microstructure of semisolids may affect the drug release. The objective of this study was to compare the microstructure-defining physical parameters of different batches of a reference ointment containing calcipotriol and betamethasone (Daivobet 50 &micro

microstructureequivalencelcsh:RS1-441Pharmaceutical Sciencegeneric semisolid formulation02 engineering and technology030226 pharmacology & pharmacyDosage formArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicinetopical drugStatisticsinter-batch variabilityEquivalence (measure theory)Parametric statisticsMathematics021001 nanoscience & nanotechnologyMicrostructureConfidence intervalReference productSample size determinationDrug releaserheology0210 nano-technologyPharmaceutics
researchProduct

Influence of Inter- and Intra-Batch Variability on the Sample Size Required for Demonstration of Equivalent Microstructure of Semisolid Dosage Forms

2020

Inter- and intra-batch variability of the quality attributes contribute to the uncertainty for demonstrating equivalent microstructure of post-approval changes and generic/hybrids of semisolid topical products. Selecting a representative sample size to describe accurately the in vitro properties of semisolids and to reach enough statistical power to demonstrate similarity between two semisolid topical products is currently challenging. The objective of this work is to establish the number of batches and units per batch to be compared based on different inter-batch and intra-batch variability to demonstrate equivalence in the physical characteristics of the products that ensure a similar mic…

Manufacturing processlcsh:RS1-441Pharmaceutical ScienceMicrostructureEquivalenceArticleStatistical powerDosage formIntra-batch variabilitylcsh:Pharmacy and materia medicaSample size determinationInter-batch variabilityBiological systemTopical productsMathematicsPharmaceutics
researchProduct

In Situ Study of the Effect of Naringin, Talinolol and Protein-Energy Undernutrition on Intestinal Absorption of Saquinavir in Rats

2011

To study the potential interactions of naringin (NAR), talinolol (TAL) and protein-energy undernutrition (PEU) in the absorption process of saquinavir (SQV), perfusion experiments were performed in the small intestine of rats at different SQV concentrations. The results obtained demonstrated that SQV intestinal absorption was described by simultaneous passive diffusion (kdif = 3.44 hr) and saturable absorption (Vma = 127.31 lM ⁄ hr; Kma =1 0.50lM) together with a capacity-limited efflux (Vms = 270.53 lM ⁄ hr; Kms =2 3.44lM). The competitive inhibition constants of NAR on the SQV input and efflux processes were (IC50)a =3 .98l Ma nd(IC50)s = 5.00 lM, respectively. NAR significantly decreased…

PharmacologyChromatographyGeneral MedicineAbsorption (skin)PharmacologyToxicologyIntestinal absorptionSmall intestinechemistry.chemical_compoundmedicine.anatomical_structurechemistryPharmacokineticsmedicineNaringinSaquinavirIC50medicine.drugTalinololBasic & Clinical Pharmacology & Toxicology
researchProduct

Enzyme-responsive silica mesoporous supports capped with azopyridinium salts for controlled delivery applications

2012

11 páginas, 7 figuras, 3 tablas y 2 esquemas

INGENIERIA DE LA CONSTRUCCIONCell SurvivalPyridinesmedia_common.quotation_subjectenzymesNanoparticleNanotechnologyPyridinium Compoundsmesoporous materialsCatalysisgated materialsHeLachemistry.chemical_compoundQUIMICA ORGANICAQUIMICA ANALITICAmedicineRhodamine BHumansGated materialsInternalizationAzopyridinium derivativemedia_commonbiologyChemistryRhodaminesOrganic ChemistryQUIMICA INORGANICAGeneral Chemistrybiology.organism_classificationSilicon DioxideCombinatorial chemistryMesoporous materialsEnzymesazopyridinium derivativeDrug deliveryDrug deliveryMCF-7 CellsNanoparticlesnanoparticlesMesoporous materialOxidoreductasesAzo CompoundsPorosityCamptothecinIntracellularmedicine.drugHeLa Cells
researchProduct

Applicability of the STOPP/START criteria to older polypathological patients in a long-term care hospital

2017

Objectives To analyse the applicability of the STOPP/START criteria as a tool to identify patients with potentially inappropriate medications (PIM) during pharmaceutical validation of prescriptions in a long-term care hospital, to identify risk factors for PIM and to characterise the physiological systems and drugs more frequently associated with these PIM. Methods An interventional, prospective and longitudinal study was conducted in polypathological patients aged >65 years. Usual pharmaceutical care and the STOPP/START criteria were used to identify PIM and to plan pharmaceutical interventions at admission. At discharge, the discharge summaries were reviewed using the STOPP/START criteria…

medicine.medical_specialtyLongitudinal studybusiness.industrySTOPP START CriteriaStopp criteriaPsychological intervention030204 cardiovascular system & hematologymedicine.diseaseComorbidity03 medical and health sciencesLong-term care0302 clinical medicinePharmaceutical carehemic and lymphatic diseasesmedicineOriginal Article030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsMedical prescriptionIntensive care medicinebusinessEuropean Journal of Hospital Pharmacy
researchProduct

Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles of a controlled release formulation.

2018

Regulatory guidelines recommend that, when a level A IVIVC is established, dissolution specification should be established using averaged data and the maximum difference between AUC and Cmax between the reference and test formulations cannot be greater than 20%. However, averaging data assumes a loss of information and may reflect a bias in the results. The objective of the current work is to present a new approach to establish dissolution specifications using a new methodology (individual approach) instead of average data (classical approach). Different scenarios were established based on the relationship between in vitro-in vivo dissolution rate coefficient using a level A IVIVC of a cont…

In vitro dissolutionCmaxPharmaceutical Science02 engineering and technologyBioequivalence021001 nanoscience & nanotechnology030226 pharmacology & pharmacyControlled releaseModels Biological03 medical and health sciencesDrug Liberation0302 clinical medicineIVIVCTherapeutic EquivalencyDelayed-Action PreparationsMaximum differenceRange (statistics)Computer Simulation0210 nano-technologyBiological systemDissolutionMonte Carlo MethodMathematicsTabletsEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Bioavailability and pharmacokinetic model for ritonavir in the rat.

2007

The aim of this study is to investigate in vivo the oral bioavailability of ritonavir and to evaluate the pharmacokinetic model that best describes the plasma concentration behavior after oral and intravenous administration. Male Wistar rats were intravenously administered at 3 mg dose of pure ritonavir and oral administered at 4.6 +/- 2.5 mg of diluted Norvir. Blood samples were taken by means of the jugular vein for a 24 h period of time. An analytical high-performance liquid chromatography (HPLC) technique was developed in order to quantify ritonavir plasma concentrations. A nonlinear modeling approach was used to estimate the pharmacokinetic parameters of interest. Results showed that a…

MaleRitonavirbiologyChemistryPharmaceutical ScienceBiological AvailabilityAbsorption (skin)PharmacologyHigh-performance liquid chromatographyModels BiologicalBioavailabilityAbsorptionRatsPharmacokineticsIn vivoEnzyme inhibitormedicinebiology.proteinAnimalsRitonavirProtease inhibitor (pharmacology)Rats Wistarmedicine.drugJournal of pharmaceutical sciences
researchProduct

Population modelling to describe pharmacokinetics of amiodarone in rats: Relevance of plasma protein and tissue depot binding

2007

The objective of this paper was to characterize the disposition phase of AM in rats, after different high doses and modalities of i.v. administration. Three fitting programs, WINNONLIN, ADAPT II and NONMEM were employed. The two-stage fitting methods led to different results, none of which can adequately explain amiodarone's behaviour, although a great amount of data per subject is available. The non-linear mixed effect modelling approach allows satisfactory estimation of population pharmacokinetic parameters, and their respective variability. The best model to define the AM pharmacokinetic profile is a two-compartment model, with saturable and dynamic plasma protein binding and linear tiss…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationAmiodaronePharmaceutical SciencePharmacologyAntiarrhythmic agentAmiodaroneModels BiologicalPharmacokineticsInternal medicineBlood plasmaAnimalsMedicineTissue DistributionDosingRats Wistareducationeducation.field_of_studyDose-Response Relationship Drugbusiness.industryBlood ProteinsBlood proteinsRatsNONMEMEndocrinologyArea Under CurveData Interpretation StatisticalInjections IntravenousbusinessAnti-Arrhythmia Agentsmedicine.drugEuropean Journal of Pharmaceutical Sciences
researchProduct

N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: In vivo study with TNBS-induced colitis model in rats

2011

5-Aminosalicylic acid (5-ASA) loaded N-Succinyl-chitosan (SucCH) microparticle and freeze-dried system were prepared as potential delivery systems to the colon. Physicochemical characterization and in vitro release and swelling studies were previously assessed and showed that the two formulations appeared to be good candidates to deliver the drug to the colon. In this work the effectiveness of these two systems in the treatment of inflammatory bowel disease was evaluated. In vitro mucoadhesive studies showed excellent mucoadhesive properties of both the systems to the inflamed colonic mucosa. Experimental colitis was induced by rectal instillation of 2,4,6-trinitrobenzene sulfonic acid (TNB…

Malemedicine.medical_specialtyAminosalicylic acidColonPolymersPharmaceutical ScienceLymphocyte ActivationInflammatory bowel diseaseGastroenterologyAbsorptionChitosanchemistry.chemical_compoundDrug Delivery SystemsIn vivoInternal medicinemedicineAnimalsIntestinal MucosaRats WistarMicroparticleColitisMesalaminePeroxidaseChitosanDrug CarriersChemistryAnti-Inflammatory Agents Non-SteroidalOrgan SizeColitismedicine.diseasedigestive system diseasesIn vitroRatsDisease Models AnimalFreeze DryingTrinitrobenzenesulfonic AcidSwellingmedicine.symptomInternational Journal of Pharmaceutics
researchProduct

Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat …

2016

Abstract Intestinal drug permeability is position dependent and pertains to a specific point along the intestinal membrane, and the resulted segmental-dependent permeability phenomenon has been recognized as a critical factor in the overall absorption of drug following oral administration. The aim of this research was to compare segmental-dependent permeability data obtained from two different rat intestinal perfusion approaches: the single-pass intestinal perfusion (SPIP) model and the closed-loop (Doluisio) rat perfusion method. The rat intestinal permeability of 12 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed…

MaleIn situDrugmedia_common.quotation_subjectAdministration OralPharmaceutical Science02 engineering and technologyPharmacology030226 pharmacology & pharmacyPermeabilityJejunum03 medical and health sciences0302 clinical medicineIleumOral administrationmedicineAnimalsRats Wistarmedia_commonIntestinal permeabilitybusiness.industry021001 nanoscience & nanotechnologyBiopharmaceutics Classification Systemmedicine.diseaseSmall intestineRatsPerfusionJejunummedicine.anatomical_structureIntestinal AbsorptionPharmaceutical Preparations0210 nano-technologybusinessPerfusionInternational Journal of Pharmaceutics
researchProduct

A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients.

2016

The objective of this study was to compare the efficacy of sofosbuvir-based treatments in patients with chronic hepatitis C virus (HCV) infection using a model-based meta-analysis (MBMA). A bibliographic search was performed to identify clinical trials involving sofosbuvir as a unique direct-acting antiviral (DAA) agent or together with daclatasvir, ledipasvir or simeprevir for the treatment of diagnosed HCV infection. The time course of the virological response (VR) was modelled to estimate the effect of treatment and the influence of population characteristics on the longitudinal efficacy profile. The model was validated and simulations of 10 different treatment schedules were performed. …

MaleMicrobiology (medical)OncologyLedipasvirSimeprevirmedicine.medical_specialtyPyrrolidinesDaclatasvirSofosbuvirHepatitis C virusPopulationHepacivirusPharmacologymedicine.disease_causeAntiviral Agents03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSimeprevirInternal medicinemedicineHepatitis C virus Meta-analysis Modelling Simulation SofosbuvirHumansPharmacology (medical)030212 general & internal medicineeducationFluoreneseducation.field_of_studybusiness.industryImidazolesValineGeneral MedicineHepatitis C ChronicModels TheoreticalClinical trialInfectious DiseaseschemistryMeta-analysisBenzimidazolesDrug Therapy CombinationFemale030211 gastroenterology & hepatologyCarbamatesSofosbuvirbusinessmedicine.drug
researchProduct

Relationship between rheological properties, in vitro release and in vivo equivalency of topical formulations of diclofenac.

2019

Determination of bioequivalence remains a challenge in generic topical drug development. To support pharmacokinetic studies, strategies to demonstrate microstructure sameness of the products being compared include in vitro evaluations, such as the comparison of rheological properties, droplet size and in vitro release rates. Nevertheless, defining the appropriate acceptance range to consider equivalence between test and reference formulation is complex. To shed more light into this issue, in vitro release and rheological properties were compared to in vivo bioequivalence data (systemic blood measurements within a clinical trial) after topical application of a single dose. Test and reference…

AdultMaleDiclofenacAdolescentAdministration TopicalPharmaceutical ScienceBiological Availability02 engineering and technologyBioequivalence030226 pharmacology & pharmacy03 medical and health sciencesYoung Adult0302 clinical medicineDiclofenacPharmacokineticsRheologyIn vivomedicineHumansMathematicsTopical drugCross-Over StudiesMiddle Aged021001 nanoscience & nanotechnologyIn vitroBioavailabilityTherapeutic EquivalencyArea Under CurveFemale0210 nano-technologyRheologyBiomedical engineeringmedicine.drugInternational journal of pharmaceutics
researchProduct

Impact of nutritional status on the pharmacokinetics of erlotinib in rats

2015

Malnourishment is a complex condition in which physiopathological changes take place in multiple systems as a result of energy, protein and nutrient deficiency. The purpose of this study was to evaluate, using an experimental animal model, the impact of nutritional status on the pharmacokinetic profile of erlotinib, a reversible, highly selective, human epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor. Two groups of rats -WN (well-nourished) and UN (undernourished) - were fed with different diets for 23-26 days. Rats were assigned randomly to one of three erlotinib treatments (n = 42) consisting of a single dose administered intravenously (i.v.), via oral solution or v…

PharmacologyDrugeducation.field_of_studymedicine.drug_classbusiness.industrymedia_common.quotation_subjectPopulationPharmaceutical ScienceCancerNutritional statusGeneral MedicineAbsorption (skin)Pharmacologymedicine.diseaseTyrosine-kinase inhibitorPharmacokineticsmedicinePharmacology (medical)Erlotinibeducationbusinessmedia_commonmedicine.drugBiopharmaceutics & Drug Disposition
researchProduct

A preclinical study to model taurine pharmokinetics in the undernourished rat

2018

AbstractMalnutrition is a common feature of chronic and acute diseases, often associated with a poor prognosis, including worsening of clinical outcome, owing, among other factors, to dysfunction of the most internal organs and systems affecting the absorption, metabolism and elimination of drugs and nutrients. Taurine is involved in numerous biological processes and is required in increased amounts in response to pathological conditions. The aim of this study was to describe the behaviour of taurine in well-nourished (WN) rats and to analyse the influence of protein–energy undernutrition on the pharmacokinetic (PK) parameters of taurine, using a PK model. Wistar rats were randomly distribu…

Male0301 basic medicineTaurineTaurinePopulationSerum albuminAdministration OralBiological AvailabilityNutritional StatusMedicine (miscellaneous)PharmacologyExcretionRandom Allocation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePharmacokineticsAnimalsMedicineDistribution (pharmacology)030212 general & internal medicineRats Wistareducationeducation.field_of_studyNutrition and DieteticsDose-Response Relationship DrugbiologyReabsorptionbusiness.industryRatsNONMEM030104 developmental biologychemistryInjections Intravenousbiology.proteinFood DeprivationbusinessBritish Journal of Nutrition
researchProduct

A multilevel object-oriented modelling methodology for physiologically-based pharmacokinetics (PBPK): Evaluation with a semi-mechanistic pharmacokine…

2019

Abstract Background and objective The aims of this study are (i) to assess the predictive reliability of the physiologically based software PhysPK versus the well-known population approach software NONMEM for the cited semi-mechanistic PK model, (ii) to determine whether these modelling approaches are interchangeable and (iii) to compare acausal with causal modelling approaches in the framework of semi-mechanistic PK models. Methods A semi-mechanistic model was proposed, which assumed oral administration of a solid dosage form with a peripheral compartment and two active metabolites. The model incorporates intestinal transit, dissolution limited by solubility, variable efflux transporter ex…

DrugPhysiologically based pharmacokinetic modellingComputer sciencemedia_common.quotation_subjectPopulationCmaxHealth InformaticsModels BiologicalDosage form030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineSoftwarePharmacokineticsPharmacokineticseducationmedia_commonVariable (mathematics)education.field_of_studybusiness.industryReproducibility of ResultsExpression (computer science)Computer Science ApplicationsNONMEMSolubilityArea Under CurvebusinessBiological system030217 neurology & neurosurgerySoftwareComputer methods and programs in biomedicine
researchProduct

Comparison of segmental-dependent permeability in human and in situ perfusion model in rat.

2017

Abstract Nowadays, alternative methods have been developed to predict intestinal permeability values in human as in vitro, in situ or ex vivo methods. They were developed by the necessity to avoid the problems of the human permeability experiments. However, determination of human permeability is needed to properly validate the alternative methods. For this reason, recently, Dahlgren et al. published an indirect method based on a deconvolution technique to estimate the human permeability in different gastrointestinal segments (jejunum, ileum and colon). Therefore, the objective of this research was to demonstrate that Doluisio technique is a useful method to predict the human permeability in…

Malemedicine.medical_specialtyColonIn situ perfusionPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyPermeability03 medical and health sciences0302 clinical medicineIleummedicineAnimalsHumansRats WistarAlternative methodsIntestinal permeabilityChemistry021001 nanoscience & nanotechnologymedicine.diseaseSurgeryPerfusionPermeability (earth sciences)JejunumAtenololIntestinal AbsorptionKetoprofenDeconvolution0210 nano-technologyBiomedical engineeringMetoprololEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Design, characterization and in vitro evaluation of 5-aminosalicylic acid loaded N-succinyl-chitosan microparticles for colon specific delivery

2011

The objective of this study was to prepare NS-chitosan microparticles for the delivery of 5-aminosalicylic acid (5-ASA) to the colon. Microparticles can spread out over a large area of colon allowing a more effective local efficacy of 5-ASA. N-Succinyl-chitosan was chosen as carrier system because of its excellent pharmaceutical properties in colon drug targeting such as poor solubility in acid environment, biocompatibility, mucoadhesive properties, and low toxicity. It was prepared by introducing succinic group into chitosan N-terminals of the glucosamine units. 5-ASA loaded NS-chitosan microparticles were prepared using spray-drying. As a control, a matrix obtained by freeze-drying techni…

BiocompatibilityCarrier systemColonStatic ElectricityBiocompatible MaterialsNanotechnologyChitosanchemistry.chemical_compoundDrug Delivery SystemsColloid and Surface ChemistryDifferential scanning calorimetryX-Ray DiffractionSpectroscopy Fourier Transform InfraredmedicineZeta potentialHumansDesiccationParticle SizePhysical and Theoretical ChemistrySolubilityMesalamineChitosanCalorimetry Differential ScanningSurfaces and InterfacesGeneral MedicineHydrogen-Ion ConcentrationMicrospheresKineticsFreeze DryingSolubilitychemistryTargeted drug deliveryMicroscopy Electron ScanningWettabilitySwellingmedicine.symptomRheologyBiotechnologyNuclear chemistryColloids and Surfaces B: Biointerfaces
researchProduct

Investigation of Different Iontophoretic Currents Profiles for Short-Term Applications in Cosmetics.

2018

[EN] This study aimed at investigating the effect of electrical current profile upon the iontophoretic transport of (i) ascorbic acid (AA) and (ii) ellagic acid (EA), into porcine skin in vitro, and the impact of the physicochemical properties of both actives on their mechanism of transport when formulated in cosmetic compositions. The experiments were performed using a proprietary iontophoretic device containing a roller to apply the formulation. Three current profiles were tested: (i) galvanic direct current (DC), (ii) square unipolar pulse current (SPC), and (iii) galvanic direct current (DC) + pulse current (PC). The skin samples were collected at different sampling points, extracted an…

Ellagic acidMaterials scienceTopical penetrationPharmaceutical Sciencelcsh:RS1-441Galvanic currentSquare unipolar pulse current030226 pharmacology & pharmacyElectromigrationArticlelcsh:Pharmacy and materia medica030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicinetopical penetrationellagic acidgalvanic currentGalvanic cellPulsed currentActive ingredientChromatographyIontophoresisDirect currentsquare unipolar pulse currentPenetration (firestop)IontophoresisiontophoresisAscorbic acidchemistryAscorbic acidascorbic acidpulsed currentEllagic acidPharmaceutics
researchProduct

Pharmacokinetic models for the saturable absorption of cefuroxime axetil and saturable elimination of cefuroxime.

2004

Since oligopeptidic drugs such as beta-lactam antibiotics share the same carriers in humans and animals, the absorption and elimination kinetics of cefuroxime (C) were investigated in rats. Plasma C concentrations were measured by liquid chromatography. Pharmacokinetics and bioavailability of C in the rat were examined after intravenous (i.v.) administration at three doses (1.78, 8.9 and 17.8mg) of cefuroxime sodium and oral administration at two doses (2.02 and 8.9mg) of cefuroxime axetil (CA). Preliminary fits using data from intravenous administration of C showed that the drug disposition kinetics were clearly nonlinear, with an increase in plasma clearance as the intravenous dose increa…

MaleTime FactorsPopulationPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyModels BiologicalIntestinal absorptionPharmacokineticsOral administrationmedicineAnimalsRats WistareducationAntibacterial agenteducation.field_of_studyCefuroximeChemistryBioavailabilityAnti-Bacterial AgentsRatsNonlinear DynamicsInjections IntravenousCefuroxime SodiumCefuroximemedicine.drugEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Effect of Age on Systemic Exposure and Haematological Toxicity of Carboplatin in Advanced Non-Small Cell Lung Cancer Patients

2011

The aim of this study was to evaluate systemic exposure to carboplatin and its haematological toxicity in patients with advanced non-small cell lung cancer both older and younger than 70 years when the target area under the curve (AUC) in elderly patients was reduced by 20%. For this purpose, a population pharmacokinetic model was developed and the haema- tological toxicity of the drug was assessed. A total of 33 patients received carboplatin on day 1 and gemcitabine (1250 mg ⁄ m 2 ) on days 1 and 8. This schedule was repeated every 21 days. The Calvert-Crokcoft-Gault formula was employed to calculate a dose of carboplatin with a target AUC of 5 mg ⁄ min. ⁄ mL in patients under 70 years and…

Pharmacologyeducation.field_of_studymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentPopulationArea under the curveGeneral MedicineNeutropeniaToxicologymedicine.diseaseGastroenterologyCarboplatinGemcitabineSurgerychemistry.chemical_compoundchemistryInternal medicineToxicitymedicineLung cancerbusinesseducationmedicine.drugBasic & Clinical Pharmacology & Toxicology
researchProduct

Evaluation of ABC gene polymorphisms on the pharmacokinetics and pharmacodynamics of capecitabine in colorectal patients: Implications for dosing rec…

2020

Aims The aims are to develop a population pharmacokinetic model of capecitabine (CAP) and its main metabolites after the oral administration of CAP in colorectal cancer patients with different polymorphisms of the ATP-binding cassette (ABC) gene and a population pharmacokinetic/pharmacodynamic model capable of accounting for the neutropenic effects, and to optimize the dosing strategy based on the polymorphisms of the ABC gene and/or the administration regimen as a single agent or in combination. Methods Forty-eight patients diagnosed with colorectal cancer were included, with 432 plasma levels of CAP, 5'-desoxi-5-fluorouridine (5'-DFUR) and 5-fluorouracil (5-FU), and 370 neutrophil observa…

Colorectal cancerPopulationPharmacologyNeutropenia030226 pharmacology & pharmacyDeoxycytidinePolymorphism Single NucleotideCapecitabine03 medical and health sciences0302 clinical medicinePharmacokineticsOral administrationAntineoplastic Combined Chemotherapy ProtocolsMedicineHumansPharmacology (medical)030212 general & internal medicineeducationCapecitabinePharmacologyeducation.field_of_studybusiness.industrymedicine.diseaseOxaliplatinPharmacodynamicsFluorouracilbusinessColorectal Neoplasmsmedicine.drugBritish journal of clinical pharmacologyREFERENCES
researchProduct

Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.

2000

The objectives of this study were to determine the oral bioavailability of cefuroxime (C) and to evaluate the pharmacokinetic model that best describes the plasma concentration behaviour following single intravenous (IV), intraperitoneal (IP) and oral single doses. The same dose of C was administered by IV, IP and oral routes to three separate groups of rats (2.02 mg of cefuroxime axetil (CA) by the oral route or 1.78 mg of cefuroxime sodium (CNa) by IV and IP route). A two-compartment open model without lag time can predict the C disposition kinetics. The influence of the administration route on the pharmacokinetic parameters and AUC values was investigated by means of a one-way analysis o…

MaleCefuroximebusiness.industryPharmaceutical ScienceAdministration OralPharmacologyBioavailabilityRatsRoute of administrationPharmacokineticsOral administrationBlood plasmaMedicineAnimalsProdrugsRats WistarbusinessCefuroximeCefuroxime SodiumAntibacterial agentmedicine.drugInternational journal of pharmaceutics
researchProduct

Preclinical models for colonic absorption, application to controlled release formulation development.

2018

Oral controlled release (CR) formulations have many benefits and have become a valuable resource for the local and systemic administration of drugs. The most important characteristic of these pharmaceutical products is that drug absorption occurs mainly in the colon. Therefore, this review analyses the physiological and physicochemical features that may affect an orally administered CR product, as well as the different strategies to develop a CR dosage form and the methods used to evaluate the formulation efficacy. The models available to study the intestinal permeability and their applicability to colonic permeability determinations are also discussed.

ColonDrug Evaluation PreclinicalPharmaceutical ScienceAdministration Oral02 engineering and technologyPharmacology030226 pharmacology & pharmacyModels BiologicalDosage form03 medical and health sciences0302 clinical medicinemedicineOral routeAnimalsHumansIntestinal permeabilityChemistryGeneral Medicine021001 nanoscience & nanotechnologymedicine.diseaseControlled releaseColonic absorptionIntestinal AbsorptionPharmaceutical PreparationsControlled-Release FormulationsDelayed-Action PreparationsDrug DesignSystemic administration0210 nano-technologyBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion

2017

Traditionally, the colon is considered a secondary intestinal segment in the drug absorption process. However, in many cases the role of colonic drug permeability cannot be overlooked. The purpose of this research was to compare colon permeability data obtained using two different rat perfusion methods the single-pass intestinal perfusion (SPIP) approach and the closed-loop (Doluisio) perfusion model. A list of 14 structurally diverse model drugs was constructed, and their rat colon permeability was studied using the two methods. The two sets of results were compared to each other, and were evaluated vs. in-vitro, ex-vivo, and in-vivo literature values. The SPIP and the Doluisio results exh…

MaleIn situAbsorption (pharmacology)Pathologymedicine.medical_specialtySingle passColonPharmaceutical Science02 engineering and technology030226 pharmacology & pharmacyPermeability03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansLarge intestineRats WistarIntestinal permeabilitybusiness.industryLarge intestinal021001 nanoscience & nanotechnologymedicine.diseaseRatsPerfusionmedicine.anatomical_structureIntestinal AbsorptionPharmaceutical PreparationsLipophilicityCaco-2 Cells0210 nano-technologybusinessPerfusionBiomedical engineeringInternational Journal of Pharmaceutics
researchProduct

Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review

2017

The etiology of undernourishment in cancer patients is multifactorial: tumor-related mechanisms (such as obstruction, metabolic abnormalities, and functionality changes) in addition to the influence of anticancer therapies, which can induce or worsen undernutrition. The evident role of undernutrition in cancer treatment outcomes suggests the need of considering nutritional status when evaluating anticancer drugs. In order to merge the available data and offer researchers and clinicians a global view of this phenomenon, the present manuscript reviews on a drug-by-drug basis the undernutrition-related pharmacokinetic and pharmacodynamic aspects of anticancer treatments. This review notes inte…

Cancer ResearchMedicine (miscellaneous)Antineoplastic AgentsPharmacologyBioinformatics030226 pharmacology & pharmacy03 medical and health sciences0302 clinical medicineOtotoxicityPharmacokineticsmedicineHumansAnthracyclinesDosingVinca AlkaloidsEtoposideCardiotoxicityNutrition and Dieteticsbusiness.industryMalnutritionNeurotoxicitymedicine.diseaseCancer treatmentMalnutritionMethotrexateOncology030220 oncology & carcinogenesisFluorouracilPharmacodynamic aspectsbusinessNutrition and Cancer
researchProduct

Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.

2010

The aim of this study was to prepare and characterize both physically and biopharmaceutically, a nortriptyline hydrochloride (NTP-HCl) patch formulated in chitosan.16 g of each chitosan patch formulation (I, II and III, see Table 1 ) was poured onto rectangular glass plates (64 cm²) at a height of 1 mm and dried for 24 h at room temperature. In order to characterize the chitosan patches, polarized microscopy, in vitro skin permeation studies by passive diffusion and iontophoresis and rheological and bioadhesion studies were performed.Polarized microscopy revealed the absence of aggregates and crystal forms of NTP-HCl in all transdermal patches after 30 days of storage. The rheological behav…

AdultMaterials scienceTransdermal patchPharmaceutical ScienceTransdermal PatchNortriptylinePharmacologyAntidepressive Agents TricyclicChitosanchemistry.chemical_compoundHumansTransdermalSkinPolarized light microscopyChitosanIontophoresisAdrenergic Uptake InhibitorsGeneral MedicineAdhesionPermeationIontophoresisMiddle AgedchemistryChemical engineeringNortriptyline HydrochlorideFemaleSmoking CessationPharmaceutical development and technology
researchProduct

Ion-pair approach coupled with nanoparticle formation to increase bioavailability of a low permeability charged drug.

2018

Abstract Atenolol is a drug widely used for the treatment of hypertension. However, the great drawback it presents is a low bioavailability after oral administration. To obtain formulations that allow to improve the bioavailability of this drug is a challenge for the pharmaceutical technology. The objective of this work was to increase the rate and extent of intestinal absorption of atenolol as model of a low permeability drug, developing a double technology strategy. To increase atenolol permeability an ion pair with brilliant blue was designed and the sustained release achieved through encapsulation in polymeric nanoparticles (NPs). The in vitro release studies showed a pH-dependent relea…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological Availability02 engineering and technology030226 pharmacology & pharmacyIntestinal absorptionPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerIn vivoOral administrationmedicineAnimalsRats WistarAntihypertensive Agentsmedia_commonChromatographyChemistryBenzenesulfonates021001 nanoscience & nanotechnologyAtenololControlled releaseBioavailabilityPLGADrug LiberationAtenololIntestinal AbsorptionNanoparticles0210 nano-technologymedicine.drugInternational journal of pharmaceutics
researchProduct

Population pharmacokinetics of 5-fluorouracil in colorectal cancer patients

2004

Aims. The pharmacokinetics of 5-fluorouracil (5-FU) after intravenous administration in color- ectal cancer patients were examined using population analysis. The relevant covariates and the extent of inter- and intraindividual variability were evaluated. Methods. Data from 27 patients with diagnosis of nonmetastatic colorectal adenocarcinoma receiving weekly 5-FU (450 mg/m2), plus levamisol 50 mg/8 hours by oral route for 3 days every 15 days, were pooled with data from 17 patients with diagnosis of metastatic colorectal adenocarcinoma, receiving daily 5-FU (425 mg/m2) and intravenous folinic acid (20 mg/m2) over five consecutive days (daily times five), every four weeks. In both groups 5-…

Oncologymedicine.medical_specialtyeducation.field_of_studyColorectal cancerbusiness.industryPopulationCancerPopulation pharmacokineticsmedicine.disease030226 pharmacology & pharmacyGastroenterology03 medical and health sciencesFolinic acid0302 clinical medicineOncologyPharmacokineticsFluorouracil030220 oncology & carcinogenesisInternal medicinemedicinePharmacology (medical)Every Four Weekseducationbusinessmedicine.drugJournal of Oncology Pharmacy Practice
researchProduct

Characterization of intestinal absorption of C -glycoside flavonoid vicenin-2 from Lychnophora ericoides leafs in rats by nonlinear mixed effects mod…

2015

Vicenin-2 (apigenin-6,8-di-C-β-d-glucopyranoside) is present in hydroalcoholic extracts of the Brazilian species Lychnophora ericoides Mart., Asteraceae, leaves, and the biological effects of this compound have been demonstrated including anti-inflammatory, antioxidant and anti-tumor effects in rat models. Given the potential of this compound as a pharmacological agent, the aims of this investigation were to evaluate the extent of intestinal absorption of vicenin-2, and to determine the intestinal permeation profile using an in situ single-pass intestinal perfusion technique. A validated HPLC–UV method was applied to measure the amount of unabsorbed vicenin-2 in the gut after an oral admini…

chemistry.chemical_classificationeducation.field_of_studyIntestinal absorptionFlavonoidPopulationlcsh:RS1-441PharmacokineticAbsorption (skin)PharmacologyIntestinal absorptionSmall intestinelcsh:Pharmacy and materia medicaPharmacology Toxicology and Pharmaceutics(all)medicine.anatomical_structurechemistryPharmacokineticsVicenin-2In vivoOral administrationFlavonoidmedicineGeneral Pharmacology Toxicology and PharmaceuticseducationRevista Brasileira de Farmacognosia
researchProduct